Evacuations and road closures were unfolding during Tuesday morning rush hour as bricks fell and columns buckled.

Following the partial floor cave-in of the old Pfizer building in Midtown on Tuesday, the developer working to convert the ...

David Werner and Nathan Berman are behind the historic project that appears to have serious structural concerns.

But the high-profile nature of the development itself, as the largest ongoing office-to-residential conversion in the U.S.

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes ...

While construction has resumed at the former Pfizer building, unionized construction workers and investigators are calling ...

A 7% dividend yield will grab your attention, but be sure to read the fine print.

Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push into obesity drugs.

Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday. President Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks ...

Jim Cramer stared down a stock yielding 7% and sitting near its 52-week low, and still would not tell viewers to buy it. On ...

Both McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise ...

These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.